O'Shaughnessy Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $335K | Buy |
+5,890
| New | +$335K | ﹤0.01% | 1578 |
|
2023
Q4 | – | Sell |
-3,542
| Closed | -$305K | – | 1791 |
|
2023
Q3 | $305K | Sell |
3,542
-284
| -7% | -$24.4K | ﹤0.01% | 1108 |
|
2023
Q2 | $357K | Buy |
3,826
+564
| +17% | +$52.6K | 0.01% | 992 |
|
2023
Q1 | $309K | Sell |
3,262
-449
| -12% | -$42.6K | ﹤0.01% | 1039 |
|
2022
Q4 | $373K | Buy |
3,711
+842
| +29% | +$84.6K | 0.01% | 888 |
|
2022
Q3 | $245K | Buy |
2,869
+473
| +20% | +$40.4K | ﹤0.01% | 1007 |
|
2022
Q2 | $206K | Sell |
2,396
-115
| -5% | -$9.89K | ﹤0.01% | 1024 |
|
2022
Q1 | $226K | Buy |
2,511
+101
| +4% | +$9.09K | ﹤0.01% | 1031 |
|
2021
Q4 | $241K | Buy |
2,410
+3
| +0.1% | +$300 | ﹤0.01% | 980 |
|
2021
Q3 | $224K | Buy |
2,407
+480
| +25% | +$44.7K | ﹤0.01% | 988 |
|
2021
Q2 | $164K | Hold |
1,927
| – | – | ﹤0.01% | 1121 |
|
2021
Q1 | $167K | Sell |
1,927
-360
| -16% | -$31.2K | ﹤0.01% | 997 |
|
2020
Q4 | $193K | Buy |
2,287
+268
| +13% | +$22.6K | 0.01% | 834 |
|
2020
Q3 | $162K | Sell |
2,019
-6
| -0.3% | -$481 | ﹤0.01% | 768 |
|
2020
Q2 | $180K | Buy |
2,025
+1,259
| +164% | +$112K | 0.01% | 674 |
|
2020
Q1 | $72K | Buy |
+766
| New | +$72K | ﹤0.01% | 707 |
|
2019
Q3 | – | Sell |
-2,084
| Closed | -$199K | – | 1258 |
|
2019
Q2 | $199K | Hold |
2,084
| – | – | ﹤0.01% | 543 |
|
2019
Q1 | $183K | Hold |
2,084
| – | – | ﹤0.01% | 552 |
|
2018
Q4 | $173K | Hold |
2,084
| – | – | ﹤0.01% | 525 |
|
2018
Q3 | $194K | Hold |
2,084
| – | – | ﹤0.01% | 557 |
|
2018
Q2 | $228K | Buy |
+2,084
| New | +$228K | ﹤0.01% | 512 |
|
2014
Q2 | – | Sell |
-118
| Closed | -$7K | – | 1052 |
|
2014
Q1 | $7K | Sell |
118
-65
| -36% | -$3.86K | ﹤0.01% | 799 |
|
2013
Q4 | $10K | Sell |
183
-17
| -9% | -$929 | ﹤0.01% | 763 |
|
2013
Q3 | $12K | Sell |
200
-19
| -9% | -$1.14K | ﹤0.01% | 726 |
|
2013
Q2 | $12K | Buy |
+219
| New | +$12K | ﹤0.01% | 708 |
|